Tokyo Tape
Sign in
← Medinet

Half-year report · Q2

2370.TEDINET S100VQZZ
Period2024-10-01 → 2025-03-31
Filed2025-05-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥405m2024-10-01 → 2025-03-31StandaloneNet sales
Revenue¥769m2023-10-01 → 2024-09-30StandaloneNet sales (5-year summary)
Revenue¥400m2023-10-01 → 2024-03-31StandaloneNet sales
Operating income−¥756m2024-10-01 → 2025-03-31StandaloneOperating income
Operating income−¥659m2023-10-01 → 2024-03-31StandaloneOperating income
Ordinary income−¥711m2024-10-01 → 2025-03-31StandaloneOrdinary income
Ordinary income−¥1.3bn2023-10-01 → 2024-09-30StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥633m2023-10-01 → 2024-03-31StandaloneOrdinary income
Profit before tax−¥704m2024-10-01 → 2025-03-31StandaloneIncome before income taxes
Profit before tax−¥633m2023-10-01 → 2024-03-31StandaloneIncome before income taxes
Net income−¥706m2024-10-01 → 2025-03-31StandaloneProfit loss
Net income−¥1.3bn2023-10-01 → 2024-09-30StandaloneNet income loss (5-year summary)
Net income−¥634m2023-10-01 → 2024-03-31StandaloneProfit loss
Total assets¥5.4bnat 2025-03-31StandaloneAssets
Total assets¥5.7bnat 2024-09-30StandaloneAssets
Total assets¥6.1bnat 2024-03-31StandaloneTotal assets (5-year summary)
Total liabilities¥1.0bnat 2025-03-31StandaloneLiabilities
Total liabilities¥509mat 2024-09-30StandaloneLiabilities
Net assets / equity¥4.4bnat 2025-03-31StandaloneNet assets
Net assets / equity¥5.2bnat 2024-09-30StandaloneNet assets
Net assets / equity¥5.6bnat 2024-03-31StandaloneNet assets (5-year summary)
Cash and deposits¥3.4bnat 2025-03-31StandaloneCash and deposits
Cash and deposits¥4.7bnat 2024-09-30StandaloneCash and deposits
Cash & equivalents¥2.4bnat 2025-03-31StandaloneCash and cash equivalents
Cash & equivalents¥4.7bnat 2024-09-30StandaloneCash and cash equivalents
Cash & equivalents¥4.9bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥4.4bnat 2023-09-30dStandaloneCash and cash equivalents
Operating cash flow−¥754m2024-10-01 → 2025-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.3bn2023-10-01 → 2024-09-30StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥573m2023-10-01 → 2024-03-31StandaloneNet cash provided by used in operating activities
Investing cash flow−¥1.5bn2024-10-01 → 2025-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥65m2023-10-01 → 2024-09-30StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥17m2023-10-01 → 2024-03-31StandaloneNet cash provided by used in investment activities
Financing cash flow−¥2m2024-10-01 → 2025-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.5bn2023-10-01 → 2024-09-30StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2023-10-01 → 2024-03-31StandaloneNet cash provided by used in financing activities
EPS (basic)¥-2.672024-10-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-5.042023-10-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-2.552023-10-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio81.5%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.1%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.2%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Shares issued264,729,198at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued264,515,306at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued256,190,306at 2024-03-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-10-01 → 2025-03-31−¥307m
jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2024-10-01 → 2025-03-31¥186,000
jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2024-10-01 → 2025-03-31¥186,000
jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2024-10-01 → 2025-03-31−¥217m
jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2024-10-01 → 2025-03-31¥405m
jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2024-10-01 → 2025-03-31¥405m
jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2024-10-01 → 2025-03-31−¥232m
—segment totalrevenue2024-10-01 → 2025-03-31¥405m
—segment totalrevenue external2024-10-01 → 2025-03-31¥405m
—segment totalsegment profit2024-10-01 → 2025-03-31−¥448m
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥286m
jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥166,000
jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥166,000
jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2023-10-01 → 2024-03-31−¥219m
jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2023-10-01 → 2024-03-31¥400m
jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2023-10-01 → 2024-03-31¥400m
jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2023-10-01 → 2024-03-31−¥154m
—segment totalrevenue2023-10-01 → 2024-03-31¥400m
—segment totalrevenue external2023-10-01 → 2024-03-31¥400m
—segment totalsegment profit2023-10-01 → 2024-03-31−¥373m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 457
ItemContextValueUnit
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember160157000JPY
Asset retirement obligations nclCurrentQuarterInstant_NonConsolidatedMember161172000JPY
Provision for share based payments nclPrior1YearInstant_NonConsolidatedMember43865000JPY
Provision for share based payments nclCurrentQuarterInstant_NonConsolidatedMember56115000JPY
Other nclPrior1YearInstant_NonConsolidatedMember36319000JPY
Other nclCurrentQuarterInstant_NonConsolidatedMember14349000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember240342000JPY
Noncurrent liabilitiesCurrentQuarterInstant_NonConsolidatedMember231638000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember509264000JPY
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember1004335000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember6486162000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember5102250000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember1327182000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember3850000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-2714945000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-705658000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-4000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-4000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember5098395000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember4400436000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember92370000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember32545000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember92370000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember32545000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember5190766000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember4432982000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember5700031000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember5437318000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember399694000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember404787000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember321255000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember345806000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember78439000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember58981000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember737196000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember814860000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-658757000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-755879000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember3334000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember6125000JPY
Gain on investments in partnership noiPrior1YTDDuration_NonConsolidatedMember20281000JPY
Gain on investments in partnership noiCurrentYTDDuration_NonConsolidatedMember30181000JPY
Reversal of allowance for doubtful accounts noiPrior1YTDDuration_NonConsolidatedMember3100000JPY
Reversal of allowance for doubtful accounts noiCurrentYTDDuration_NonConsolidatedMember3100000JPY
Income for cancellation of manufacturing noiPrior1YTDDuration_NonConsolidatedMember4622000JPY
Income for cancellation of manufacturing noiCurrentYTDDuration_NonConsolidatedMember5350000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember1407000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember1817000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember32745000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember46573000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2024-09-30pass rounding
balance sheet identitynon_consolidated 2025-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · operating cash flownon_consolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flownon_consolidated 2024-10-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2023-10-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2024-10-01/2025-03-31pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass